ClinicalTrials.gov
ClinicalTrials.gov Menu

Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00677703
Recruitment Status : Completed
First Posted : May 14, 2008
Last Update Posted : November 19, 2012
Sponsor:
Information provided by (Responsible Party):
Paula Castano, Columbia University

Brief Summary:
Teen girls and young women taking birth control pills may forget to take their pills or may stop taking them altogether. This places them at risk for unintended pregnancies. Most young women own cell phones and use them for text messaging. We will test whether contraceptive continuation is affected after six months of daily text message reminders.

Condition or disease Intervention/treatment Phase
Contraceptives, Oral Other: Daily Text Messages Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 968 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: The Effect of Text Message Reminders on Contraceptive Continuation, a Randomized Controlled Trial
Study Start Date : January 2008
Actual Primary Completion Date : April 2010
Actual Study Completion Date : July 2012

Arm Intervention/treatment
No Intervention: Standard Care
Participants will receive standard care without daily reminders.
Experimental: Text Messages
Participants will receive a daily text message reminder for 6 months
Other: Daily Text Messages

Text message reminders to take oral contraception daily:

Each text message will be a short educational message listing the benefits of contraceptive use and providing instructions for avoiding common medication errors.

Other Name: Text Messaging




Primary Outcome Measures :
  1. contraceptive continuation [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. change in contraceptive knowledge scores [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 24 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • aged <25 years requesting OC as their primary method of contraception
  • currently sexually active or anticipating sexual activity within the next 30 days
  • owns cell phone with text messaging capability

Exclusion Criteria:

  • contraindications to combined hormonal contraception per clinic protocol (e.g., hypertension)
  • previous participation in this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00677703


Locations
United States, New York
Planned Parenthood Boro Hall
Brooklyn, New York, United States, 11201
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Paula M Castano, MD, MPH Columbia University

Publications of Results:
Other Publications:
Responsible Party: Paula Castano, Assistant Clinical Professor, Columbia University
ClinicalTrials.gov Identifier: NCT00677703     History of Changes
Other Study ID Numbers: AAAC1600
First Posted: May 14, 2008    Key Record Dates
Last Update Posted: November 19, 2012
Last Verified: November 2012

Keywords provided by Paula Castano, Columbia University:
birth control pills
contraception
continuation
text messaging
contraceptive continuation
contraceptive knowledge

Additional relevant MeSH terms:
Contraceptive Agents
Reproductive Control Agents
Physiological Effects of Drugs